Preliminary results of a phase I trial with dose escalated lenalidomide (L) in separate cohorts of relapsed acute leukemia (AL) or chronic lymphocytic leukemia (CLL): evidence of activity in acute myeloid leukemia (AML) and toxicity in CLL at starting dose

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 7075-7075 ◽  
Author(s):  
W. G. Blum ◽  
L. A. Andritsos ◽  
A. J. Johnson ◽  
R. B. Klisovic ◽  
C. Kefauver ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Chronic Lymphocytic Leukemia ◽  
Acute Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Phase I Trial ◽  
Lymphocytic Leukemia ◽  
Preliminary Results ◽  
Starting Dose ◽  
Acute Myeloid

scholarly journals A Case of Acute Myeloid Leukemia Concurrent With Untreated Chronic Lymphocytic Leukemia

2017 ◽  
Vol 37 (4) ◽  
pp. 336-338
Author(s):  
Hye-Young Lee ◽  
Chan-Jeoung Park ◽  
Enkyung You ◽  
Young-Uk Cho ◽  
Seongsoo Jang ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Chronic Lymphocytic Leukemia ◽  
Myeloid Leukemia ◽  
Lymphocytic Leukemia ◽  
Acute Myeloid

scholarly journals Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0123416 ◽  
Author(s):  
Panagiotis D. Kottaridis ◽  
Janet North ◽  
Maria Tsirogianni ◽  
Chloe Marden ◽  
Edward R. Samuel ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Natural Killer Cells ◽  
Phase I ◽  
Natural Killer ◽  
Myeloid Leukemia ◽  
Phase I Trial ◽  
Two Stage ◽  
Killer Cells ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document